Literature DB >> 16014894

Responsiveness to cetuximab without mutations in EGFR.

Zenta Tsuchihashi, Shirin Khambata-Ford, Nasser Hanna, Pasi A Jänne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16014894     DOI： 10.1056/NEJM200507143530218

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

Review 1.  EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?

Authors:  Shailender Singh Kanwar; Jyoti Nautiyal; Adhip P N Majumdar
Journal:  Curr Drug Targets       Date:  2010-06       Impact factor: 3.465

2.  [25 years of the Association of Middle-German Otorhinolaryngologists (MDHNO)].

Authors:  H Gudziol
Journal:  HNO       Date:  2017-09       Impact factor: 1.284

Review 3.  Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy.

Authors:  J C Becker; C Muller-Tidow; H Serve; W Domschke; T Pohle
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

4.  Transcriptional profiling by sequencing of oropharyngeal cancer.

Authors:  Rebecca R Laborde; Vivian W Wang; Todd M Smith; N Eric Olson; Steven M Olsen; Joaquín J García; Kerry D Olsen; Eric J Moore; Jan L Kasperbauer; Nicole M Tombers; David I Smith
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

Review 5.  Impact of heart disease and quality of care on minority populations in the United States.

Authors:  Garth N Graham; Mayadallia Guendelman; Benjamin S Leong; Sara Hogan; Adrienne Dennison
Journal:  J Natl Med Assoc       Date:  2006-10       Impact factor: 1.798

Review 6.  Trial Watch: Radioimmunotherapy for oncological indications.

Authors:  Norma Bloy; Jonathan Pol; Gwenola Manic; Ilio Vitale; Alexander Eggermont; Jérôme Galon; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-12-13       Impact factor: 8.110

7.  Acinar cell carcinomas of the pancreas: a molecular analysis in a series of 57 cases.

Authors:  Frank Bergmann; Sebastian Aulmann; Bence Sipos; Matthias Kloor; Anja von Heydebreck; Johannes Schweipert; Andreas Harjung; Philipp Mayer; Werner Hartwig; Gerhard Moldenhauer; David Capper; Gerhard Dyckhoff; Kolja Freier; Esther Herpel; Anja Schleider; Peter Schirmacher; Gunhild Mechtersheimer; Günter Klöppel; Hendrik Bläker
Journal:  Virchows Arch       Date:  2014-10-09       Impact factor: 4.064

Review 8.  EGFR and colon cancer: a clinical view.

Authors:  J de Castro-Carpeño; C Belda-Iniesta; E Casado Sáenz; E Hernández Agudo; J Feliu Batlle; M González Barón
Journal:  Clin Transl Oncol       Date:  2008-01       Impact factor: 3.405

9.  Reirradiation plus EGFR inhibition in locally recurrent and unresectable head and neck cancer: final results from a single institution.

Authors:  D Milanović; B Jeremić; A L Grosu; G Rücker; M Henke
Journal:  Strahlenther Onkol       Date:  2013-07-18       Impact factor: 3.621

Review 10.  Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer.

Authors:  Hui-Yan Luo; Rui-Hua Xu
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.